Cyprus biotech firm sees losses widen to €3.46m

Cyprus-based biotechnology company iDNA Genomics Public Ltd on Monday announced that it approved its audited consolidated financial statements for 2025, reporting a wider loss and a sharp deterioration in its balance sheet compared with the previous year. The company’s board…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Cyprus Mail.